Matteo Chiara1, Elena Di Pierro2, Ilaria Primon3, Letizia Tarantini4, Luca Agnelli5, Valentina Brancaleoni3, Francesca Granata3, Valentina Bollati4. 1. Dipartimento di Bioscienze, Università degli Studi di Milano, Milan, Italy. 2. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UOC Medicina Generale, Milan, Italy. elena.dipierro@policlinico.mi.it. 3. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UOC Medicina Generale, Milan, Italy. 4. EPIGET-Epidemiology, Epigenetics and Toxicology Lab Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy. 5. Department of Oncology and Hemato-oncology, University of Milan; and Hematology 1, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Abstract
PURPOSE: Existing data do not explain the reason why some individuals homozygous for the hypomorphic FECH allele develop erythropoietic protoporphyria (EPP) while the majority are completely asymptomatic. This study aims to identify novel possible genetic variants contributing to this variable phenotype. METHODS: High-throughput resequencing of the FECH gene, qualitative analysis of RNA, and quantitative DNA methylation examination were performed on a cohort of 72 subjects. RESULTS: A novel deep intronic variant was found in four homozygous carriers developing a clinically overt disease. We demonstrate that this genetic variant leads to the insertion of a pseudo-exon containing a stop codon in the mature FECH transcript by the abolition of an exonic splicing silencer site and the concurrent institution of a new methylated CpG dinucleotide. Moreover, we show that the hypomorphic FECH allele is linked to a single haplotype of about 20 kb in size that encompasses three noncoding variants that were previously associated with expression quantitative trait loci (eQTLs). CONCLUSION: This study confirms that intronic variants could explain the variability in the clinical manifestations of EPP. Moreover, it supports the hypothesis that the control of the FECH gene expression can be mediated through a methylation-dependent modulation of the precursor messenger RNA (pre-mRNA) splicing pattern.
PURPOSE: Existing data do not explain the reason why some individuals homozygous for the hypomorphic FECH allele develop erythropoietic protoporphyria (EPP) while the majority are completely asymptomatic. This study aims to identify novel possible genetic variants contributing to this variable phenotype. METHODS: High-throughput resequencing of the FECH gene, qualitative analysis of RNA, and quantitative DNA methylation examination were performed on a cohort of 72 subjects. RESULTS: A novel deep intronic variant was found in four homozygous carriers developing a clinically overt disease. We demonstrate that this genetic variant leads to the insertion of a pseudo-exon containing a stop codon in the mature FECH transcript by the abolition of an exonic splicing silencer site and the concurrent institution of a new methylated CpG dinucleotide. Moreover, we show that the hypomorphic FECH allele is linked to a single haplotype of about 20 kb in size that encompasses three noncoding variants that were previously associated with expression quantitative trait loci (eQTLs). CONCLUSION: This study confirms that intronic variants could explain the variability in the clinical manifestations of EPP. Moreover, it supports the hypothesis that the control of the FECH gene expression can be mediated through a methylation-dependent modulation of the precursor messenger RNA (pre-mRNA) splicing pattern.
Authors: Chumei Li; Elena Di Pierro; Valentina Brancaleoni; Maria Domenica Cappellini; David P Steensma Journal: Clin Chem Lab Med Date: 2009 Impact factor: 3.694
Authors: Giovanna Graziadei; Lorena Duca; Francesca Granata; Giacomo De Luca; Anna De Giovanni; Valentina Brancaleoni; Isabella Nava; Elena Di Pierro Journal: Front Physiol Date: 2022-03-03 Impact factor: 4.566
Authors: Giovanni Genovese; Carlo Alberto Maronese; Chiara Moltrasio; Roberta Piccinno; Dario Antonio Marletta; Giacomo De Luca; Giovanna Graziadei; Francesca Granata; Elena Di Pierro; Maria Domenica Cappellini; Angelo Valerio Marzano Journal: Photodermatol Photoimmunol Photomed Date: 2021-08-30 Impact factor: 3.254